FUNDING CANCER - Gateway for Cancer Research Grant Program (Multiple Mechanisms)
Sponsor: Gateway for Cancer Research
Description: Gateway funds phase I and II patient-centered cancer clinical trials that have the potential to shift the paradigm for standard of care. (1) The Traditional Grant Program funds early phase clinical trials for all cancer types over a period of 2-5 years, with award amounts ranging from $200,000 - $1.5M. (2) The Joint NCI/SPORE/P20 Program offers additional support to SPORE and P20 awardees to enable PIs to expand their clinical trial. (3) The Integrative Research Award funds integrative oncology research that pairs conventional therapies with evidence-based, complementary therapies to manage symptoms and side effects from treatment. (4) The Joint Society for Integrative Oncology (SIO) Program supports integrative clinical trials conducted by PIs with SIO membership. (5) The Decentralized Clinical Trial Initiative funds research leveraging site-less, technology-informed trials with the objective of bringing clinical trials to patients' doorsteps through decentralized care, telemedicine, and more. (6) Gateway's collaboration with ECOG-ACRIN aims to expand innovative phase II trials into the community with a mission to reduce the burden of cancer by leveraging ECOG-ACRIN's network of cancer centers and hospitals.
LOI Due: May 15, 2026
To view all current UVACCC funding opportunities, please click here.
For all open cancer-related funding opportunities, please click here.